Immuneering Corporation (IMRX)
NASDAQ · Healthcare
Immuneering Corporation Total Liabilities 2020–2023
Immuneering Corporation annual/quarterly total liabilities history from 2020 to 2023. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Immuneering Corporation total liabilities for the quarter ending December 31, 2023 were 12.0M, a 4.06% decrease year-over-year.
- Immuneering Corporation total liabilities for 2023 were 12.0M, a 4.06% decrease from 2022.
- Immuneering Corporation total liabilities for 2022 were 12.5M, a 16.71% increase from 2021.
- Immuneering Corporation total liabilities for 2021 were 10.7M, a 282.94% increase from 2020.
- Immuneering Corporation total liabilities for 2020 were 2.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Immuneering Corporation Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2023 | $12 |
| 2022 | $13 |
| 2021 | $11 |
| 2020 | $3 |
| Immuneering Corporation Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2023-12-31 | $12 |
| 2022-12-31 | $13 |
| 2021-12-31 | $11 |
| 2020-12-31 | $3 |
Immuneering Corporation Total Liabilities — FAQ
Immuneering Corporation (IMRX) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMRX's total liabilities history?
The chart and table above show Immuneering Corporation's total liabilities by year and by quarter, including the growth rate.